Facephi BiometriaSTU:8FB -2.21%70 EBITDA Margin % is 41.24% as of Dec. 2025, which is 245% above its 10-year median of 11.96. GuruFocus rates STU:8FB with a GF Score™ of 70/100 and a GF Value™ of €2.84 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 2,820 Software companies, Facephi Biometria ranks better than 80.32% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Facephi Biometria's EBITDA for the
six
months ended in Dec. 2025 was €9.64 Mil. Facephi Biometria's Revenue for the
six
months ended in Dec. 2025 was €23.37 Mil. Therefore, Facephi Biometria's EBITDA margin for the quarter that ended in Dec. 2025 was 41.24%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Facephi Biometria EBITDA Margin % Related Terms
Facephi Biometria EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Facephi Biometria's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:8FB vs CRM, SHOP, UBER: EBITDA Margin % Comparison
For the Software - Application subindustry, Facephi Biometria's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Facephi Biometria EBITDA Margin % vs Software Industry
For the Software industry and Technology sector, Facephi Biometria's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Facephi Biometria's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Facephi Biometria (STU:8FB) has a EBITDA Margin % of 41.24% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Facephi Biometria and its competitors. This is 245% above median its historical median of 11.96. According to the industry distribution chart, Facephi Biometria ranks #555 out of 2820 companies in the Software industry, placing it in the top 19.7%.
Is Facephi Biometria's EBITDA Margin % too high?
Facephi Biometria's current EBITDA Margin % of 41.24% is 245% above median its 10-year median of 11.96. The Software industry median EBITDA Margin % is 8.07. Facephi Biometria's value of 41.24% is 411% above this industry median. Based on the distribution chart, Facephi Biometria ranks #555 out of 2820 companies in the Software industry, which is in the top quartile — a strong position relative to peers. Overall, Facephi Biometria has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Facephi Biometria's EBITDA Margin % compare to CRM and SHOP?
According to the Software industry distribution chart, Facephi Biometria ranks #555 out of 2820 companies for EBITDA Margin %. This places Facephi Biometria in the top 20% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 8.07. Facephi Biometria's value of 41.24% is 411% above this benchmark. While the company's 10-year median is 11.96 vs. the industry median of 8.07, Facephi Biometria has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Software company?
The median EBITDA Margin % among Software companies is 8.07, based on 2,820 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Facephi Biometria's current EBITDA Margin % of 41.24% is 411% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Facephi Biometria and its competitors. For the Software industry, the median EBITDA Margin % is 8.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Facephi Biometria's current EBITDA Margin % is 41.24%, which is 245% above median its own 10-year median of 11.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Facephi Biometria stock overvalued right now?
Based on GuruFocus' analysis, Facephi Biometria (STU:8FB) is currently considered Significantly Undervalued. The stock's GF Value™ is €2.84, compared to a current price of €2.00 — trading 29.8% below its estimated fair value. The current EBITDA Margin % is 41.24%, which is 245% above median its 10-year median of 11.96 and 411% above the Software industry median of 8.07. Facephi Biometria's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Facephi Biometria (STU:8FB), the current EBITDA Margin % is 41.24% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Facephi Biometria (STU:8FB) Overvalued in 2026?
Based on GuruFocus' analysis, Facephi Biometria stock appears to be undervalued.
The current stock price of €2.00 is trading 29.8% below its estimated GF Value™ of €2.84.
GuruFocus considers Facephi Biometria to be Significantly Undervalued.
Key valuation signals for STU:8FB:
EBITDA Margin %: 41.24% (245% above median its 10-year median of 11.96)
GF Value™: €2.84 vs. price of €2.00 (29.8% below fair value)
Industry Position: 411% above the Software median (#555 of 2820)
No single metric tells the full story. See the STU:8FB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Facephi Biometria SA is a technology company specializing in digital identity verification, fraud prevention, and regulatory compliance solutions. It delivers an AI/ML-powered Identity & Anti-Fraud platform that provides a comprehensive 360-degree end-to-end approach to digital protection. It develops solutions that make digital processes safer, more accessible, and fraud-free. Its technologies help prevent identity theft while ensuring the ethical management and protection of personal data. Geographically, it operates in Spain and the rest of Countries with the majority of the revenue from the rest of Countries.
70GF Score
Get the complete analysis for STU:8FB
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:8FB has been successfully added to your 
